SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-18-017133
Filing Date
2018-12-10
Accepted
2018-12-10 15:12:53
Documents
4
Period of Report
2018-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 TO FORM 8-K f8k101618a1_optimizerxcorp.htm 8-K/A 40475
2 AUDITED FINANCIAL STATEMENTS FOR CARESPEAK f8k101618a1ex99-2_optimizerx.htm EX-99.2 135813
3 REVIEWED FINANCIAL STATEMENTS FOR CARESPEAK f8k101618a1ex99-3_optimizerx.htm EX-99.3 52529
4 UNAUDITED PRO FORMA FINANCIAL INFORMATION f8k101618a1ex99-4_optimizerx.htm EX-99.4 155427
  Complete submission text file 0001213900-18-017133.txt   385442
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38543 | Film No.: 181225995
SIC: 7389 Services-Business Services, NEC